a<p>Median number of years from first symptoms of MS to inclusion.</p>b<p>Treatment within 4 months before baseline CSF sample.</p>c<p>Three patients were treated with high-dose corticosteroids, in addition to interferon-β (2 patients) and glatiramer acetate (1 patient) respectively, due to relapses.</p>***<p>p<0.0005 compared with MS patients using independent samples t-test.</p><p>Abbreviations: RRMS = relapsing-remitting MS; PRMS = progressive MS with superimposed relapses; HC = healthy controls, EDSS = Expanded Disability Status Scale; CSF = cerebrospinal fluid, NA = not applicable.</p
a<p>Disabled RRMS subjects defined as those with EDSS ≥3.5 and T25FW >5 seconds at baseline.</p>b<p>...
<p>Abbreviations: NCAND, Non-CNS-autoimmune neurological disorders; CAND, CNS-autoimmune neurologica...
Background and Purpose: Early relapse outcomes in long-term stable patients switching from interfero...
1<p>Two or more oligoclonal bands in CSF at isoelectric focusing that were not present in serum.</p>...
<p>EDSS, Expanded Disability Status Score; RRMS, patients with relapsing-remitting multiple sclerosi...
<p>Data shown are median and range, except specified. CR: Complete remission; CSF: Cerebrospinal flu...
a<p>Number of relapses in prior 24 months for MS231.</p><p>MS, multiple sclerosis; SPMS, secondary p...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0098588#pone-0098588-t001" ...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
Current treatments for relapsing remitting multiple sclerosis (RRMS) reduce inflammation, but have a...
Background The increase in disease-modifying drugs (DMDs) allows individualization of treatment in r...
<p>Abbreviations: EDSS = Expanded Disability Scale Status; GEL = gadolinium enhancing lesions; m...
<p>RRMS = Relapsing-remitting Multiple Sclerosis, Pub.Year = Year of Publication, N = patients in pl...
There are few long-term clinical and magnetic resonance imaging (MRI) data on patients treated with ...
<p>Table 2 shows the demographics and clinical data of the patient cohort. These demographic and cli...
a<p>Disabled RRMS subjects defined as those with EDSS ≥3.5 and T25FW >5 seconds at baseline.</p>b<p>...
<p>Abbreviations: NCAND, Non-CNS-autoimmune neurological disorders; CAND, CNS-autoimmune neurologica...
Background and Purpose: Early relapse outcomes in long-term stable patients switching from interfero...
1<p>Two or more oligoclonal bands in CSF at isoelectric focusing that were not present in serum.</p>...
<p>EDSS, Expanded Disability Status Score; RRMS, patients with relapsing-remitting multiple sclerosi...
<p>Data shown are median and range, except specified. CR: Complete remission; CSF: Cerebrospinal flu...
a<p>Number of relapses in prior 24 months for MS231.</p><p>MS, multiple sclerosis; SPMS, secondary p...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0098588#pone-0098588-t001" ...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
Current treatments for relapsing remitting multiple sclerosis (RRMS) reduce inflammation, but have a...
Background The increase in disease-modifying drugs (DMDs) allows individualization of treatment in r...
<p>Abbreviations: EDSS = Expanded Disability Scale Status; GEL = gadolinium enhancing lesions; m...
<p>RRMS = Relapsing-remitting Multiple Sclerosis, Pub.Year = Year of Publication, N = patients in pl...
There are few long-term clinical and magnetic resonance imaging (MRI) data on patients treated with ...
<p>Table 2 shows the demographics and clinical data of the patient cohort. These demographic and cli...
a<p>Disabled RRMS subjects defined as those with EDSS ≥3.5 and T25FW >5 seconds at baseline.</p>b<p>...
<p>Abbreviations: NCAND, Non-CNS-autoimmune neurological disorders; CAND, CNS-autoimmune neurologica...
Background and Purpose: Early relapse outcomes in long-term stable patients switching from interfero...